{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:08Z","timestamp":1787889968824,"version":"build-2784847793"},"reference-count":343,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19) pandemic situations without establishing clinical effectiveness or tailoring safety. A repurposing strategy might be more effective and successful if pharmacogenetic interventions are being considered in future clinical studies\/trials. Although it is very unlikely that there are almost no pharmacogenetic data for COVID-19 drugs, however, from inferring the pharmacokinetic (PK)\/pharmacodynamic(PD) properties and some pharmacogenetic evidence in other diseases\/clinical conditions, it is highly likely that pharmacogenetic associations are also feasible in at least some COVID-19 drugs. We strongly mandate to undertake a pharmacogenetic assessment for at least these drug\u2013gene pairs (atazanavir\u2013<jats:italic>UGT1A1<\/jats:italic>, <jats:italic>ABCB1<\/jats:italic>, <jats:italic>SLCO1B1<\/jats:italic>, <jats:italic>APOA5<\/jats:italic>; efavirenz\u2013<jats:italic>CYP2B6<\/jats:italic>; nevirapine\u2013<jats:italic>HLA<\/jats:italic>, <jats:italic>CYP2B6<\/jats:italic>, <jats:italic>ABCB1<\/jats:italic>; lopinavir\u2013<jats:italic>SLCO1B3<\/jats:italic>, <jats:italic>ABCC2<\/jats:italic>; ribavirin\u2013<jats:italic>SLC28A2<\/jats:italic>; tocilizumab\u2013<jats:italic>FCGR3A<\/jats:italic>; ivermectin\u2013<jats:italic>ABCB1<\/jats:italic>; oseltamivir\u2013<jats:italic>CES1<\/jats:italic>, <jats:italic>ABCB1<\/jats:italic>; clopidogrel\u2013<jats:italic>CYP2C19<\/jats:italic>, <jats:italic>ABCB1<\/jats:italic>, warfarin\u2013<jats:italic>CYP2C9<\/jats:italic>, <jats:italic>VKORC1<\/jats:italic>; non-steroidal anti-inflammatory drugs (NSAIDs)\u2013<jats:italic>CYP2C9<\/jats:italic>) in COVID-19 patients for advancing precision medicine. Molecular docking and computational studies are promising to achieve new therapeutics against SARS-CoV-2 infection. The current situation in the discovery of anti-SARS-CoV-2 agents at four important targets from <jats:italic>in silico<\/jats:italic> studies has been described and summarized in this review. Although natural occurring compounds from different herbs against SARS-CoV-2 infection are favorable, however, accurate experimental investigation of these compounds is warranted to provide insightful information. Moreover, clinical considerations of drug\u2013drug interactions (DDIs) and drug\u2013herb interactions (DHIs) of the existing repurposed drugs along with pharmacogenetic (e.g., efavirenz and <jats:italic>CYP2B6<\/jats:italic>) and herbogenetic (e.g., andrographolide and <jats:italic>CYP2C9<\/jats:italic>) interventions, collectively called multifactorial drug\u2013gene interactions (DGIs), may further accelerate the development of precision COVID-19 therapies in the real-world clinical settings.<\/jats:p>","DOI":"10.3389\/fphar.2022.835136","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T07:07:16Z","timestamp":1645168036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies"],"prefix":"10.3389","volume":"13","author":[{"given":"Mohitosh","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nares","family":"Sawajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyada","family":"Rungrotmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonpan","family":"Sanachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Ershadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00292-021-00918-9","article-title":"COVID-19: Effects on the Lungs and Heart","volume":"42","author":"Ackermann","year":"2021","journal-title":"Pathologe"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1128\/JVI.00998-13","article-title":"Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry that Act by Three Distinct Mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A Living WHO Guideline on Drugs for Covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179124","article-title":"Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations","volume":"22","author":"Ahmad","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3389\/fimmu.2020.01979","article-title":"Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections","volume":"11","author":"Ahmed-Hassan","year":"2020","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10070824","article-title":"Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling","volume":"10","author":"Al-Sanea","year":"2021","journal-title":"Antibiot"},{"key":"B8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jcph.1788","article-title":"Antiretrovirals for Prophylaxis against COVID-19: A Comprehensive Literature Review","volume":"61","author":"Alavian","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/jmv.26699","article-title":"Risk Factors Prediction, Clinical Outcomes, and Mortality in COVID-19 Patients","volume":"93","author":"Alizadehsani","year":"2021","journal-title":"J. Med. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2014.10.030","article-title":"Role of Pharmacogenetic in Ribavirin Outcome Prediction and Pharmacokinetics in an Italian Cohort of HCV-1 and 4 Patients","volume":"69","author":"Allegra","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 Vaccines: Status Report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080805","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection","volume":"14","author":"Ambrocio-Ortiz","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"115860","DOI":"10.1016\/j.bmc.2020.115860","article-title":"Protease Targeted COVID-19 Drug Discovery and its Challenges: Insight into Viral Main Protease (Mpro) and Papain-like Protease (PLpro) Inhibitors","volume":"29","author":"Amin","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"112559","DOI":"10.1016\/j.ejmech.2020.112559","article-title":"Fight against Novel Coronavirus: A Perspective of Medicinal Chemists","volume":"201","author":"Amin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-021-01671-0","article-title":"Efficacy and Safety of Remdesivir in Hospitalised COVID-19 Patients: a Systematic Review and Meta-Analysis","author":"Angamo","year":"2021","journal-title":"Infection"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1080\/07391102.2020.1779819","article-title":"Drug Repurposing against SARS-CoV-2 Using E-Pharmacophore Based Virtual Screening, Molecular Docking and Molecular Dynamics with Main Protease as the Target","volume":"39","author":"Arun","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2125.2006.02759.x","article-title":"Pharmacodynamic Interaction Studies of Ginkgo Biloba with Cilostazol and Clopidogrel in Healthy Human Subjects","volume":"63","author":"Aruna","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B18","first-page":"101","article-title":"Common Herbal Dietary Supplement-Drug Interactions","volume":"96","author":"Asher","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"B19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2217\/pme.14.7","article-title":"Toxicogenetics of Lopinavir\/ritonavir in HIV-Infected European Patients","volume":"11","author":"Aspiroz","year":"2014","journal-title":"Per. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.1038\/s41598-020-70351-0","article-title":"Effect of Drug Metabolizing Enzymes and Transporters in Thai Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy","volume":"10","author":"Atasilp","year":"2020","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"n436","DOI":"10.1136\/bmj.n436","article-title":"Severe Covid-19 Pneumonia: Pathogenesis and Clinical Management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41397-021-00209-9","article-title":"Pharmacogenomics and COVID-19: Clinical Implications of Human Genome Interactions with Repurposed Drugs","volume":"21","author":"Badary","year":"2021","journal-title":"Pharmacogenomics J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"109133","DOI":"10.1016\/j.celrep.2021.109133","article-title":"Hepatitis C Virus Drugs that Inhibit SARS-CoV-2 Papain-like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture","volume":"35","author":"Bafna","year":"2021","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.08.100","article-title":"Identification of SARS-CoV-2 Inhibitors from Extracts of Houttuynia Cordata Thunb","author":"Bahadur Gurung","year":"2021","journal-title":"Saudi J. Biol. Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061678","article-title":"Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study","volume":"26","author":"Baig","year":"2021","journal-title":"Molecules"},{"key":"B26","doi-asserted-by":"publisher","first-page":"104773","DOI":"10.1016\/j.meegid.2021.104773","article-title":"Variants in ACE2; Potential Influences on Virus Infection and COVID-19 Severity","volume":"90","author":"Bakhshandeh","year":"2021","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","article-title":"Mechanisms of Homocysteine-Induced Damage to the Endothelial, Medial and Adventitial Layers of the Arterial wall","volume":"173","author":"Balint","year":"2020","journal-title":"Biochimie"},{"key":"B28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11883-020-00880-6","article-title":"Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-Analysis of 28,872 Patients","volume":"22","author":"Baral","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652","article-title":"Targeting Potential Drivers of COVID-19: Neutrophil Extracellular Traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMc1917344","article-title":"Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations","volume":"383","author":"Baudou","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11239-020-02120-9","article-title":"Covid-19 Treatment Update: Follow the Scientific Evidence","volume":"50","author":"Becker","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41431-020-0691-z","article-title":"ACE2 Gene Variants May Underlie Interindividual Variability and Susceptibility to COVID-19 in the Italian Population","volume":"28","author":"Benetti","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3949\/ccjm.87a.20047","article-title":"COVID-19: Coronavirus Replication, Pathogenesis, and Therapeutic Strategies","volume":"87","author":"Bergmann","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41397-020-0151-8","article-title":"Association Study of Genetic Polymorphisms in Proteins Involved in Oseltamivir Transport, Metabolism, and Interactions with Adverse Reactions in Mexican Patients with Acute Respiratory Diseases","volume":"20","author":"Berm\u00fadez de Le\u00f3n","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"110622","DOI":"10.1016\/j.biopha.2020.110622","article-title":"Propolis and its Potential against SARS-CoV-2 Infection Mechanisms and COVID-19 Disease: Running Title: Propolis against SARS-CoV-2 Infection and COVID-19","volume":"131","author":"Berretta","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-Of-The-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1792871","article-title":"Risk of Major Adverse Cardiovascular Events of CYP2C19 Loss-Of-Function Genotype Guided Prasugrel\/ticagrelor vs Clopidogrel Therapy for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: a Meta-Analysis","author":"Biswas","year":"","journal-title":"Platelets"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2021-0098","article-title":"Association of CYP2C19 Loss-Of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Meta-Analysis","author":"Biswas","year":"2022","journal-title":"Pharmacogenomics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41397-020-00196-3","article-title":"Global Distribution of CYP2C19 Risk Phenotypes Affecting Safety and Effectiveness of Medications","volume":"21","author":"Biswas","year":"","journal-title":"Pharmacogenomics J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1038\/s41598-021-84678-9","article-title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers with Risk of Mortality, Severity or SARS-CoV-2 Test Positivity in COVID-19 Patients: Meta-Analysis","volume":"11","author":"Biswas","year":"","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07142-w","article-title":"Association of CYP2C19 Loss-Of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-Analysis","author":"Biswas","year":"","journal-title":"Cardiovasc. Drugs Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1017\/exp.2020.53","article-title":"Potential Clinically Significant Life-Threatening Drug\u2013Drug Interactions of Lopinavir and Ritonavir Used in the Treatment of COVID-19","volume":"1","author":"Biswas","year":"2020","journal-title":"Exp. Results"},{"key":"B43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/pgs-2020-0096","article-title":"Predictive Association of ABCB1 C3435T Genetic Polymorphism with the Efficacy or Safety of Lopinavir and Ritonavir in COVID-19 Patients","volume":"22","author":"Biswas","year":"","journal-title":"Pharmacogenomics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47363\/jvrr\/2021(2)129","article-title":"Predictive Prevalence of Risk Phenotypes Associated with Rs2285666 Single Nucleotide Polymorphism of ACE2 in the World Population Susceptible to SARS-CoV-2 Infection","volume":"2","author":"Biswas","year":"","journal-title":"J. Viro Res. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000512592","article-title":"Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis","volume":"64","author":"Biswas","year":"","journal-title":"Intervirology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1080\/14740338.2020.1836152","article-title":"Effects of the ABCB1 C3435T Single Nucleotide Polymorphism on Major Adverse Cardiovascular Events in Acute Coronary Syndrome or Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention and Treated with Clopidogrel: A Systematic Revie","volume":"19","author":"Biswas","year":"","journal-title":"Expert Opin. Drug Saf."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s11096-021-01261-y","article-title":"Risk of Major Adverse Cardiovascular Events for Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Patients Inheriting CYP2C19 Loss-Of-Function Alleles: Meta-Analysis","volume":"43","author":"Biswas","year":"","journal-title":"Int. J. Clin. Pharm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e14710","DOI":"10.1111\/ijcp.14710","article-title":"Potential Clinically Significant Drug-Drug Interactions of Hydroxychloroquine Used in the Treatment of COVID-19","author":"Biswas","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkv208","article-title":"Successful Pharmacogenetics-Based Optimization of Unboosted Atazanavir Plasma Exposure in HIV-Positive Patients: a Randomized, Controlled, Pilot Study (The REYAGEN Study)","volume":"70","author":"Bonora","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.12688\/f1000research.24143.1","article-title":"In Silico screening of Known Small Molecules to Bind ACE2 Specific RBD on Spike Glycoprotein of SARS-CoV-2 for Repurposing against COVID-19","volume":"9","author":"Br","year":"2020","journal-title":"F1000Research"},{"key":"B51","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.healun.2015.01.009","article-title":"Oral Ribavirin for Respiratory Syncytial Virus Infection after Lung Transplantation: Efficacy and Cost-Efficiency","volume":"34","author":"Burrows","year":"2015","journal-title":"J. Hear. Lung Transpl. Off. Publ. Int. Soc. Hear. Transpl."},{"key":"B52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/PGPM.S270069","article-title":"Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease","volume":"13","author":"Cafiero","year":"2020","journal-title":"Pharmgenomics. Pers. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/nejmoa2001282","article-title":"A Trial of Lopinavir\u2013Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"982689","DOI":"10.1155\/2013\/982689","article-title":"Andrographis Paniculata Extract and Andrographolide Modulate the Hepatic Drug Metabolism System and Plasma Tolbutamide Concentrations in Rats","author":"Chen","year":"20132013","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: a Descriptive Study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12575-021-00142-y","article-title":"Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death","volume":"23","author":"Chen","year":"2021","journal-title":"Biol. Proced. Online"},{"key":"B57","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1389200211209050640","article-title":"Herb-drug Interactions and Mechanistic and Clinical Considerations","volume":"13","author":"Chen","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jep.2015.01.010","article-title":"Herb-drug Interaction between an Anti-HIV Chinese Herbal SH Formula and Atazanavir In Vitro and In Vivo","volume":"162","author":"Cheng","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082800","article-title":"Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection","volume":"13","author":"Cheng","year":"2021","journal-title":"Nutrients"},{"key":"B60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3343\/alm.2021.41.2.129","article-title":"Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19","volume":"41","author":"Choudhary","year":"2021","journal-title":"Ann. Lab. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00705-020-04628-0","article-title":"The Emergence of SARS, MERS and Novel SARS-2 Coronaviruses in the 21st century","volume":"165","author":"da Costa","year":"2020","journal-title":"Arch. Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/FPC.0000000000000169","article-title":"Polymorphisms Associated with Renal Adverse Effects of Antiretroviral Therapy in a Southern Brazilian HIV Cohort","volume":"25","author":"da Rocha","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2478\/acph-2021-0016","article-title":"Identification of Potential COVID-19 Main Protease Inhibitors Using Structure-Based Pharmacophore Approach, Molecular Docking and Repurposing Studies","volume":"71","author":"Daoud","year":"2021","journal-title":"Acta Pharm."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-021-10226-2","article-title":"Identification of Phytocompounds from Houttuynia Cordata Thunb. As Potential Inhibitors for SARS-CoV-2 Replication Proteins through GC-MS\/LC-MS Characterization, Molecular Docking and Molecular Dynamics Simulation","author":"Das","year":"","journal-title":"Mol. Divers."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1080\/07391102.2020.1763201","article-title":"An Investigation into the Identification of Potential Inhibitors of SARS-CoV-2 Main Protease Using Molecular Docking Study","volume":"39","author":"Das","year":"","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26113213","article-title":"Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries","volume":"26","author":"David","year":"2021","journal-title":"Molecules"},{"key":"B67","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/pgs.16.22","article-title":"Pharmacogenetics of Ribavirin-Induced Anemia in HCV Patients","volume":"17","author":"D\u2019Avolio","year":"2016","journal-title":"Pharmacogenomics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/21623945.2021.1965315","article-title":"Resveratrol Supplementation Reduces ACE2 Expression in Human Adipose Tissue","volume":"10","author":"de Ligt","year":"2021","journal-title":"Adipocyte"},{"key":"B69","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent Insights into Emerging Coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B70","volume-title":"Warfarin Therapy and VKORC1 and CYP Genotype","author":"Dean","year":"2012"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ph14070655","article-title":"ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential","volume":"14","author":"Deb","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1002\/slct.202100854","article-title":"Identification of SARS-CoV-2 Main Protease Inhibitors Using Structure Based Virtual Screening and Molecular Dynamics Simulation of DrugBank Database","volume":"6","author":"Debnath","year":"2021","journal-title":"ChemistrySelect"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1016\/j.csbj.2021.05.053","article-title":"Interaction of 8-Anilinonaphthalene-1-Sulfonate with SARS-CoV-2 Main Protease and its Application as a Fluorescent Probe for Inhibitor Identification","volume":"19","author":"Deetanya","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1128\/AAC.02282-12","article-title":"Pharmacokinetics, Metabolism, and Excretion of the Antiviral Drug Arbidol in Humans","volume":"57","author":"Deng","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/ptr.5691","article-title":"Effect of Ginkgo Biloba Extract on the Pharmacokinetics and Metabolism of Clopidogrel in Rats","volume":"30","author":"Deng","year":"2016","journal-title":"Phytother. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/cpt.1477","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy","volume":"106","author":"Desta","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060855","article-title":"Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?","volume":"11","author":"Diomede","year":"2021","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","first-page":"109934","DOI":"10.1016\/j.mehy.2020.109934","article-title":"The Effects of Allium Sativum on Immunity within the Scope of COVID-19 Infection","volume":"144","author":"Donma","year":"2020","journal-title":"Med. Hypotheses"},{"key":"B79","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The Spike Protein of SARS-CoV-Aa Target for Vaccine and Therapeutic Development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182105","article-title":"Association between the UGT1A1*28 Allele and Hyperbilirubinemia in HIV-Positive Patients Receiving Atazanavir: a Meta-Analysis","volume":"39","author":"Du","year":"2019","journal-title":"Biosci. Rep."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: Pharmacokinetics and Concerns about Clinical Trials for 2019-nCoV Infection","author":"Du","year":"2020","journal-title":"Clin. Pharmacol. Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: A Review of its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of \u03b2-d-N(4)-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"584894","DOI":"10.3389\/fchem.2020.584894","article-title":"Identification of a New Potential SARS-COV-2 RNA-dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations","volume":"8","author":"El Hassab","year":"2020","journal-title":"Front. Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, Nucleotide Inhibitors, Repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2187","DOI":"10.1002\/rmv.2187","article-title":"Efficacy and Safety of Remdesivir in Hospitalized Covid-19 Patients: Systematic Review and Meta-Analysis Including Network Meta-Analysis","volume":"31","author":"Elsawah","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"B87","unstructured":"Summary on Compassionate Use: Remdesivir Gilead2020"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1080\/07391102.2020.1801510","article-title":"Anthocyanin Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease: An In-Silico Perspective of Therapeutic Targets against COVID-19 Pandemic","volume":"39","author":"Fakhar","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B89","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/ejhpharm-2020-002613","article-title":"A Prospective, Observational Study to Evaluate Adverse Drug Reactions in Patients with COVID-19 Treated with Remdesivir or Hydroxychloroquine: a Preliminary Report","volume":"28","author":"Falc\u00e3o","year":"2021","journal-title":"Eur. J. Hosp. Pharm. Sci. Pract."},{"key":"B90","doi-asserted-by":"publisher","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and Molecular Modelling Studies Reveal a New Mechanism of Action of Chloroquine and Hydroxychloroquine against SARS-CoV-2 Infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.sjbs.2021.02.066","article-title":"Screening of Inhibitors against SARS-CoV-2 Spike Protein and Their Capability to Block the Viral Entry Mechanism: A Viroinformatics Study","volume":"28","author":"Farouk","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2021.1965914","article-title":"Molecular Dynamics Simulation, 3D-Pharmacophore and Scaffold Hopping Analysis in the Design of Multi-Target Drugs to Inhibit Potential Targets of COVID-19","author":"Fayyazi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B93","unstructured":"Remdesivir EUA Letter of Authorization\n            Fda\n          2020"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01168-20","article-title":"A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality","volume":"64","author":"Fern\u00e1ndez-Cruz","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B95","doi-asserted-by":"publisher","first-page":"107613","DOI":"10.1016\/j.pharmthera.2020.107613","article-title":"Therapeutic Potential of Resveratrol against Emerging Respiratory Viral Infections","volume":"214","author":"Filardo","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00825-20","article-title":"Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production","volume":"64","author":"Fintelman-Rodrigues","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fimmu.2017.01475","article-title":"HLA Class I or Class II and Disease Association: Catch the Difference if You Can","volume":"8","author":"Fiorillo","year":"2017","journal-title":"Front. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-like Protease","volume":"6","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/v13030413","article-title":"Pharmacogenetics Approach for the Improvement of COVID-19 Treatment","volume":"13","author":"Fricke-Galindo","year":"2021","journal-title":"Viruses"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.269","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing","volume":"99","author":"Gammal","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10238-020-00671-y","article-title":"Emerging Treatment Strategies for COVID-19 Infection","volume":"21","author":"Gavriatopoulou","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/genes11091044","article-title":"Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19","volume":"11","author":"Gemmati","year":"2020","journal-title":"Genes (Basel)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/cryst11050471","article-title":"Virtual Screening and Molecular Docking Studies for Discovery of Potential RNA-dependent RNA Polymerase Inhibitors","volume":"11","author":"Ghazwani","year":"2021","journal-title":"Crystals"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1021\/acs.jcim.1c00258","article-title":"Pharmacophore Model for SARS-CoV-2 3CLpro Small-Molecule Inhibitors and In Vitro Experimental Validation of Computationally Screened Inhibitors","volume":"61","author":"Glaab","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"B106","first-page":"2460","article-title":"Relationship between Genetic Polymorphisms of Drug Efflux Transporter MDR1 (ABCB1) and Response to Losartan in Hypertension Patients","volume":"20","author":"G\u00f6kta\u015f","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The Pharmacokinetics and Interactions of Ivermectin in Humans-Aa Mini-Review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"AAPS J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir Promotes SARS-CoV-2 Mutagenesis via the RNA Template","volume":"297","author":"Gordon","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"111966","DOI":"10.1016\/j.fct.2020.111966","article-title":"Promising Phytochemicals of Traditional Indian Herbal Steam Inhalation Therapy to Combat COVID-19 - an In Silico Study","volume":"148","author":"Gowrishankar","year":"2021","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"B110","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1021\/ar970146b","article-title":"From Knowledge-Based Potentials to Combinatorial lead Design In Silico","volume":"35","author":"Grzybowski","year":"2002","journal-title":"Acc. Chem. Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.eclinm.2021.100849","article-title":"Efficacy of the TMPRSS2 Inhibitor Camostat Mesilate in Patients Hospitalized with Covid-19-A Double-Blind Randomized Controlled Trial","volume":"35","author":"Gunst","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11239-014-1101-6","article-title":"D-dimer Elevation and Adverse Outcomes","volume":"39","author":"Halaby","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B115","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00228-009-0624-9","article-title":"Effect of Silymarin on the Pharmacokinetics of Losartan and its Active Metabolite E-3174 in Healthy Chinese Volunteers","volume":"65","author":"Han","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/s1734-1140(09)70140-9","article-title":"Influence of ABCB1 Gene Polymorphisms on the Pharmacokinetics of Azithromycin Among Healthy Chinese Han Ethnic Subjects","volume":"61","author":"He","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7150\/ijms.51935","article-title":"Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy","volume":"18","author":"Ho","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What Defines an Efficacious COVID-19 Vaccine? A Review of the Challenges Assessing the Clinical Efficacy of Vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/3934","article-title":"From Genomics to Vaccines: Malaria as a Model System","volume":"4","author":"Hoffman","year":"1998","journal-title":"Nat. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/FPC.0b013e32835a450b","article-title":"Genome-wide Association Study of Plasma Efavirenz Pharmacokinetics in AIDS Clinical Trials Group Protocols Implicates Several CYP2B6 Variants","volume":"22","author":"Holzinger","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","article-title":"New Insights into Genetic Susceptibility of COVID-19: an ACE2 and TMPRSS2 Polymorphism Analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"","journal-title":"Nat. Rev. Microbiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"153242","DOI":"10.1016\/j.phymed.2020.153242","article-title":"Efficacy and Safety of Lianhuaqingwen Capsules, a Repurposed Chinese Herb, in Patients with Coronavirus Disease 2019: A Multicenter, Prospective, Randomized Controlled Trial","volume":"85","author":"Hu","year":"","journal-title":"Phytomedicine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1073\/pnas.1902649116","article-title":"Select Sequencing of Clonally Expanded CD8(+) T Cells Reveals Limits to Clonal Expansion","volume":"116","author":"Huang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/v13050826","article-title":"Scutellaria Barbata D. Don Inhibits the Main Proteases (M(pro) and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection","volume":"13","author":"Huang","year":"2021","journal-title":"Viruses"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ptr.6895","article-title":"Revisiting Pharmacological Potentials of Nigella Sativa Seed: A Promising Option for COVID-19 Prevention and Cure","volume":"35","author":"Islam","year":"2021","journal-title":"Phytother. Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1124\/dmd.110.037259","article-title":"CYP2C9-mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay","volume":"39","author":"Iwamura","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"B130","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2021.05.022","article-title":"Risk of Stroke in CYP2C19 LoF Polymorphism Carrier Coronary Artery Disease Patients Undergoing Clopidogrel Therapy: An Ethnicity-Based Updated Meta-Analysis","volume":"90","author":"Jafrin","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425255.2021.1946514","article-title":"Genotyping HLA Alleles to Predict the Development of Severe Cutaneous Adverse Drug Reactions (SCARs): State-Of-The-Art","author":"Jantararoungtong","year":"","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080783","article-title":"TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia","volume":"11","author":"Jantararoungtong","year":"","journal-title":"J. Pers. Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.taap.2007.07.008","article-title":"Strong Synergistic Induction of CYP1A1 Expression by Andrographolide Plus Typical CYP1A Inducers in Mouse Hepatocytes","volume":"224","author":"Jaruchotikamol","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"45553","DOI":"10.1038\/srep45553","article-title":"HLA-B*15:21 and Carbamazepine-Induced Stevens-Johnson Syndrome: Pooled-Data and In Silico Analysis","volume":"7","author":"Jaruthamsophon","year":"2017","journal-title":"Sci. Rep."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients","author":"Jayk Bernal","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/jcph.1341","article-title":"FCGR2A\/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients with Rheumatoid Arthritis","volume":"59","author":"Jim\u00e9nez Morales","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and Discovery of its Inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update","volume":"102","author":"Johnson","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e44064","DOI":"10.1371\/journal.pone.0044064","article-title":"Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: a Systematic Review and Meta-Analysis","volume":"7","author":"Jorgensen","year":"2012","journal-title":"PLoS One"},{"key":"B142","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1080\/07391102.2020.1760137","article-title":"Discovery of Potential Multi-Target-Directed Ligands by Targeting Host-specific SARS-CoV-2 Structurally Conserved Main Protease","volume":"39","author":"Joshi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B143","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of Molnupiravir-Induced SARS-CoV-2 Mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1080\/07391102.2020.1784291","article-title":"Repurposing of FDA-Approved Antivirals, Antibiotics, Anthelmintics, Antioxidants, and Cell Protectives against SARS-CoV-2 Papain-like Protease","volume":"39","author":"Kandeel","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1825232","article-title":"Repurposing Drugs for Treatment of SARS-CoV-2 Infection: Computational Design Insights into Mechanisms of Action","author":"Kandwal","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/jpm9010007","article-title":"Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants","volume":"9","author":"Kanuri","year":"2019","journal-title":"J. Pers. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1860133","article-title":"Anisotine and Amarogentin as Promising Inhibitory Candidates against SARS-CoV-2 Proteins: a Computational Investigation","author":"Kar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B148","doi-asserted-by":"publisher","first-page":"647693","DOI":"10.3389\/fmicb.2021.647693","article-title":"Combining SARS-CoV-2 Proofreading Exonuclease and RNA-dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput In Silico Screening","volume":"12","author":"Khater","year":"2021","journal-title":"Front. Microbiol."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168604","article-title":"Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e106275","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and Inhibition of the Papain-like Protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of Thrombotic Complications in Critically Ill ICU Patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092890","article-title":"Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review","volume":"9","author":"Klomp","year":"2020","journal-title":"J. Clin. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"107717","DOI":"10.1016\/j.jmgm.2020.107717","article-title":"Molecular Modelling Investigation for Drugs and Nutraceuticals against Protease of SARS-CoV-2","volume":"101","author":"Kodchakorn","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"B154","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41588-018-0168-y","article-title":"Common Variation Near IRF6 Is Associated with IFN-\u03b2-Induced Liver Injury in Multiple Sclerosis","volume":"50","author":"Kowalec","year":"2018","journal-title":"Nat. Genet."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting Enzyme 2: a Functional Receptor for SARS Coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/tan.14284","article-title":"The Influence of HLA Genotype on the Severity of COVID-19 Infection","volume":"98","author":"Langton","year":"2021","journal-title":"HLA"},{"key":"B159","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43450-021-00162-5","article-title":"Flavonoids from Siparuna Cristata as Potential Inhibitors of SARS-CoV-2 Replication","author":"Leal","year":"2021","journal-title":"Rev. Bras. Farmacogn. Orgao da Soc. Bras. Farmacogn."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent Enhancement and SARS-CoV-2 Vaccines and Therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.11.017","article-title":"Curcumin Use in Pulmonary Diseases: State of the Art and Future Perspectives","volume":"115","author":"Lelli","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/fcp.12586","article-title":"Potential Drug-Drug Interactions Associated with Drugs Currently Proposed for COVID-19 Treatment in Patients Receiving Other Treatments","volume":"34","author":"Lemaitre","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cbi.2005.11.002","article-title":"Interaction of Ivermectin with Multidrug Resistance Proteins (MRP1, 2 and 3)","volume":"159","author":"Lespine","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.apsb.2021.02.011","article-title":"Corilagin Inhibits SARS-CoV-2 Replication by Targeting Viral RNA-dependent RNA Polymerase","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/diseases4030026","article-title":"Human Coronaviruses: A Review of Virus-Host Interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Dis. (Basel, Switzerland)"},{"key":"B168","doi-asserted-by":"publisher","first-page":"605688","DOI":"10.3389\/fimmu.2020.605688","article-title":"Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience","volume":"11","author":"Littera","year":"2020","journal-title":"Front. Immunol."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100455","article-title":"Drug Repurposing for the SARS-CoV-2 Papain-like Protease","author":"Liu","year":"2021","journal-title":"ChemMedChem"},{"key":"B170","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and Biochemical Indexes from 2019-nCoV Infected Patients Linked to Viral Loads and Lung Injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.medin.2020.08.004","article-title":"HLA Genetic Polymorphisms and Prognosis of Patients with COVID-19","volume":"45","author":"Lorente","year":"2021","journal-title":"Med. Intensiva"},{"key":"B172","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/FPC.0b013e328336eee4","article-title":"ADME Pharmacogenetics: Investigation of the Pharmacokinetics of the Antiretroviral Agent Lopinavir Coformulated with Ritonavir","volume":"20","author":"Lubomirov","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"B173","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/17425255.2020.1744563","article-title":"An Update on the Pharmacogenomics of NSAID Metabolism and the Risk of Gastrointestinal Bleeding","volume":"16","author":"Mac\u00edas","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12985-020-01457-0","article-title":"Analysis of the Efficacy of HIV Protease Inhibitors against SARS-CoV-2\u2019s Main Protease","volume":"17","author":"Mahdi","year":"2020","journal-title":"Virol. J."},{"key":"B175","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3831\/KPI.2020.23.010","article-title":"Prophetic Medicine-Nigella Sativa (Black Cumin Seeds) - Potential Herb for COVID-19?","volume":"23","author":"Maideen","year":"2020","journal-title":"J. Pharmacopuncture"},{"key":"B176","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/tpj.2016.88","article-title":"Influence of IL6R Gene Polymorphisms in the Effectiveness to Treatment with Tocilizumab in Rheumatoid Arthritis","volume":"18","author":"Maldonado-Montoro","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"B177","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.phrs.2016.06.016","article-title":"Genetic and Clinical Biomarkers of Tocilizumab Response in Patients with Rheumatoid Arthritis","volume":"111","author":"Maldonado-Montoro","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaci.2020.07.008","article-title":"Emerging Treatments in COVID-19: Adverse Drug Reactions Including Drug Hypersensitivities","volume":"146","author":"Manjaly Thomas","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1128\/AAC.02384-13","article-title":"CYP2B6 18492T->C Polymorphism Compromises Efavirenz Concentration in Coinfected HIV and Tuberculosis Patients Carrying CYP2B6 Haplotype *1\/*1","volume":"58","author":"Manosuthi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acsptsci.0c00216","article-title":"Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule In Vitro Repurposing Screen","volume":"4","author":"Maria","year":"2021","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"B181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to Nevirapine Hypersensitivity Associated with HLA-Drb1*0101 and Abrogated by Low CD4 T-Cell Counts","volume":"19","author":"Martin","year":"2005","journal-title":"AIDS"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus","volume":"64","author":"Martinez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2021.1936183","article-title":"Screening of Potential Bio-Molecules from Moringa Olifera against SARS-CoV-2 Main Protease Using Computational Approaches","author":"Mathpal","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B184","doi-asserted-by":"publisher","first-page":"103492","DOI":"10.1016\/j.resp.2020.103492","article-title":"Pros and Cons of Corticosteroid Therapy for COVID-19 Patients","volume":"280","author":"Mattos-Silva","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"B186","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/FPC.0000000000000145","article-title":"PharmGKB Summary: Efavirenz Pathway, Pharmacokinetics","volume":"25","author":"McDonagh","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"B187","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2147\/NDT.S101580","article-title":"Clinically Relevant Genetic Variants of Drug-Metabolizing Enzyme and Transporter Genes Detected in Thai Children and Adolescents with Autism Spectrum Disorder","volume":"12","author":"Medhasi","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e00245820","DOI":"10.1590\/0102-311X00245820","article-title":"Adverse Drug Reactions in Patients with COVID-19 in Brazil: Analysis of Spontaneous Notifications of the Brazilian Pharmacovigilance System","volume":"37","author":"Melo","year":"2021","journal-title":"Cad. Saude Publica"},{"key":"B189","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/AAC.01082-10","article-title":"Herb-drug Interaction between Echinacea Purpurea and Darunavir-Ritonavir in HIV-Infected Patients","volume":"55","author":"Molt\u00f3","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B190","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40262-013-0057-6","article-title":"Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients","volume":"52","author":"Molt\u00f3","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"B191","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2017.03.014","article-title":"Curcumin Inhibits Zika and Chikungunya Virus Infection by Inhibiting Cell Binding","volume":"142","author":"Mounce","year":"2017","journal-title":"Antivir. Res"},{"key":"B192","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.031","article-title":"The Role of Neutrophil Extracellular Traps in Covid-19: Only an Hypothesis or a Potential New Field of Research?","volume":"191","author":"Mozzini","year":"2020","journal-title":"Thromb. Res."},{"key":"B193","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2125.2009.03516.x","article-title":"A Novel Polymorphism in ABCB1 Gene, CYP2B6*6 and Sex Predict Single-Dose Efavirenz Population Pharmacokinetics in Ugandans","volume":"68","author":"Mukonzo","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1002\/jmv.27003","article-title":"Association between the HLA Genotype and the Severity of COVID-19 Infection Among South Asians","volume":"93","author":"Naemi","year":"2021","journal-title":"J. Med. Virol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1080\/07391102.2020.1794972","article-title":"Cyanobacterial Metabolites as Promising Drug Leads against the M(pro) and PL(pro) of SARS-CoV-2: an In Silico Analysis","volume":"39","author":"Naidoo","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B196","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13659-020-00253-1","article-title":"Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences","volume":"10","author":"Narkhede","year":"2020","journal-title":"Nat. Prod. Bioprospect."},{"key":"B197","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.26355\/eurrev_202011_23861","article-title":"Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 Treatment","volume":"24","author":"Nastri","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s40121-021-00515-6","article-title":"A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2","volume":"10","author":"Nathan","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080742","article-title":"Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study","volume":"14","author":"Nawrot-Hadzik","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021946118","article-title":"Structure of the SARS-CoV-2 RNA-dependent RNA Polymerase in the Presence of Favipiravir-RTP","volume":"118","author":"Naydenova","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2515690X21996662","DOI":"10.1177\/2515690X21996662","article-title":"Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections","volume":"26","author":"Ng","year":"2021","journal-title":"J. Evidence-based Integr. Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The Case of Complement Activation in COVID-19 Multiorgan Impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"B203","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/tan.14047","article-title":"HLA Allele Frequencies and Susceptibility to COVID-19 in a Group of 99 Italian Patients","volume":"96","author":"Novelli","year":"2020","journal-title":"HLA"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1021\/acs.biochem.0c00160","article-title":"Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms","volume":"59","author":"Nutho","year":"2020","journal-title":"Biochemistry"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113561","article-title":"Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines","volume":"9","author":"Omersel","year":"2020","journal-title":"J. Clin. Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11418-011-0516-z","article-title":"In Vitro determination of the Effect of Andrographis Paniculata Extracts and Andrographolide on Human Hepatic Cytochrome P450 Activities","volume":"65","author":"Pan","year":"2011","journal-title":"J. Nat. Med."},{"key":"B207","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jiph.2020.12.037","article-title":"Essential Oils as an Effective Alternative for the Treatment of COVID-19: Molecular Interaction Analysis of Protease (M(pro)) with Pharmacokinetics and Toxicological Properties","volume":"14","author":"Panikar","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"B208","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/acsnano.0c07383","article-title":"Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing","volume":"15","author":"Pathak","year":"2021","journal-title":"ACS Nano"},{"key":"B209","doi-asserted-by":"publisher","first-page":"100345","DOI":"10.1016\/j.imu.2020.100345","article-title":"Molecular Docking and Dynamic Simulations for Antiviral Compounds against SARS-CoV-2: A Computational Study","volume":"19","author":"Peele","year":"2020","journal-title":"Inform. Med. unlocked"},{"key":"B210","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cbi.2008.10.054","article-title":"Effects of Andrographis Paniculata Extract and Andrographolide on Hepatic Cytochrome P450 mRNA Expression and Monooxygenase Activities after In Vivo Administration to Rats and In Vitro in Rat and Human Hepatocyte Cultures","volume":"179","author":"Pekthong","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"B211","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jep.2007.10.013","article-title":"Differential Inhibition of Rat and Human Hepatic Cytochrome P450 by Andrographis Paniculata Extract and Andrographolide","volume":"115","author":"Pekthong","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1592\/phco.30.8.797","article-title":"Echinacea Purpurea Significantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir-Ritonavir Exposure in Healthy Subjects","volume":"30","author":"Penzak","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B213","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12967-015-0682-y","article-title":"Relationship between ITPA Polymorphisms and Hemolytic Anemia in HCV-Infected Patients after Ribavirin-Based Therapy: a Meta-Analysis","volume":"13","author":"Pineda-Tenor","year":"2015","journal-title":"J. Transl. Med."},{"key":"B214","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in Vaccine Immune Response: the Role of Immunogenetics and the Emerging Field of Vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B215","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized Vaccinology: A Review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"key":"B216","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cpt.2288","article-title":"Pharmacogenomics and Vaccine Development","volume":"110","author":"Poland","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B217","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers Associated with COVID-19 Disease Progression","volume":"57","author":"Ponti","year":"","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"109859","DOI":"10.1016\/j.mehy.2020.109859","article-title":"Homocysteine as a Potential Predictor of Cardiovascular Risk in Patients with COVID-19","volume":"143","author":"Ponti","year":"","journal-title":"Med. Hypotheses"},{"key":"B219","doi-asserted-by":"publisher","first-page":"106564","DOI":"10.1016\/j.bpc.2021.106564","article-title":"Evaluation of Potential Anti-RNA-dependent RNA Polymerase (RdRP) Drugs against the Newly Emerged Model of COVID-19 RdRP Using Computational Methods","volume":"272","author":"Poustforoosh","year":"2021","journal-title":"Biophys. Chem."},{"key":"B220","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3389\/fmicb.2019.00912","article-title":"Anti-infective Properties of the Golden Spice Curcumin","volume":"10","author":"Praditya","year":"2019","journal-title":"Front. Microbiol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1039\/c5fo00485c","article-title":"Curcumin and its Analogues: a Potential Natural Compound against HIV Infection and AIDS","volume":"6","author":"Prasad","year":"2015","journal-title":"Food Funct."},{"key":"B222","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fgene.2014.00478","article-title":"HLA-B Allele and Haplotype Diversity Among Thai Patients Identified by PCR-SSOP: Evidence for High Risk of Drug-Induced Hypersensitivity","volume":"5","author":"Puangpetch","year":"2014","journal-title":"Front. Genet."},{"key":"B223","doi-asserted-by":"publisher","first-page":"724935","DOI":"10.1155\/2015\/724935","article-title":"Significant Association of HLA-B Alleles and Genotypes in Thai Children with Autism Spectrum Disorders: A Case-Control Study","volume":"2015","author":"Puangpetch","year":"2015","journal-title":"Dis. Markers"},{"key":"B224","doi-asserted-by":"publisher","first-page":"20584","DOI":"10.1038\/s41598-020-77602-0","article-title":"In Silico studies Evidenced the Role of Structurally Diverse Plant Secondary Metabolites in Reducing SARS-CoV-2 Pathogenesis","volume":"10","author":"Puttaswamy","year":"2020","journal-title":"Sci. Rep."},{"key":"B225","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1080\/07391102.2020.1776639","article-title":"Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication, post-translational Modification and Host Immunity Evasion Infection Mechanisms","volume":"39","author":"Quimque","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B226","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/17425255.2012.680886","article-title":"An Update on the Ability of St. John\u2019s Wort to Affect the Metabolism of Other Drugs","volume":"8","author":"Rahimi","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25102271","article-title":"Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)","volume":"25","author":"Rahman","year":"2020","journal-title":"Molecules"},{"key":"B228","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and Pharmacological Properties of Hydroxychloroquine and Chloroquine in Treatment of Systemic Lupus Erythematosus, Rheumatoid Arthritis and Related Diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology"},{"key":"B229","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/FTD.0b013e318225384f","article-title":"CYP3A5, ABCB1, and SLCO1B1 Polymorphisms and Pharmacokinetics and Virologic Outcome of Lopinavir\/ritonavir in HIV-Infected Children","volume":"33","author":"Rakhmanina","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"B230","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled Budesonide in the Treatment of Early COVID-19 (STOIC): a Phase 2, Open-Label, Randomised Controlled Trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B231","doi-asserted-by":"publisher","first-page":"602841","DOI":"10.3389\/fphar.2020.602841","article-title":"Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data","volume":"11","author":"Ram\u00edrez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.immuni.2016.09.015","article-title":"Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion","volume":"45","author":"Ranasinghe","year":"2016","journal-title":"Immunity"},{"key":"B233","doi-asserted-by":"publisher","first-page":"e00705","DOI":"10.1002\/prp2.705","article-title":"Drug-drug Interactions with Candidate Medications Used for COVID-19 Treatment: An Overview","volume":"9","author":"Rezaee","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B234","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1111\/bph.15206","article-title":"Non-steroidal Anti-inflammatory Drugs, Prostaglandins, and COVID-19","volume":"177","author":"Robb","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1185\/030079908x260871","article-title":"Effect of Ginkgo Biloba Extract on Lopinavir, Midazolam and Fexofenadine Pharmacokinetics in Healthy Subjects","volume":"24","author":"Robertson","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"B236","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/QAD.0b013e328011d7c1","article-title":"Genetic Factors Influencing Atazanavir Plasma Concentrations and the Risk of Severe Hyperbilirubinemia","volume":"21","author":"Rodr\u00edguez-N\u00f3voa","year":"2007","journal-title":"AIDS"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3390\/life10070106","article-title":"Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance","volume":"10","author":"Rombol\u00e0","year":"2020","journal-title":"Life (Basel, Switzerland)"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26030632","article-title":"Current Updates on Naturally Occurring Compounds Recognizing Sars-Cov-2 Druggable Targets","volume":"26","author":"Romeo","year":"2021","journal-title":"Molecules"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer Level in COVID-19 Infection: a Systematic Review","volume":"13","author":"Rostami","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tifs.2020.08.006","article-title":"Antiviral Potential of Garlic (Allium Sativum) and its Organosulfur Compounds: A Systematic Update of Pre-clinical and Clinical Data","volume":"104","author":"Rouf","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen Exerts Anti-viral and Anti-inflammatory Activity against Novel Coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity Profiling and crystal Structures of Inhibitor-Bound SARS-CoV-2 Papain-like Protease: A Framework for Anti-COVID-19 Drug Design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061549","article-title":"Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 M(pro)","volume":"26","author":"Saeed","year":"2021","journal-title":"Molecules"},{"key":"B244","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"B246","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fphar.2020.00078","article-title":"Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics","volume":"11","author":"Satapornpong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1208\/s12248-020-00465-w","article-title":"Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy","volume":"22","author":"Scherrmann","year":"2020","journal-title":"AAPS J."},{"key":"B248","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of Action of Hydroxychloroquine and Chloroquine: Implications for Rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B250","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update","volume":"94","author":"Scott","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B251","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2021.1898475","article-title":"Potentiality of Moringa Oleifera against SARS-CoV-2: Identified by a Rational Computer Aided Drug Design Method","author":"Sen","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B253","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/PGPM.S44006","article-title":"Association of CYP3A4\/5, ABCB1 and ABCC2 Polymorphisms and Clinical Outcomes of Thai Breast Cancer Patients Treated with Tamoxifen","volume":"6","author":"Sensorn","year":"2013","journal-title":"Pharmgenomics. Pers. Med."},{"key":"B254","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2147\/OTT.S100905","article-title":"ABCB1 and ABCC2 and the Risk of Distant Metastasis in Thai Breast Cancer Patients Treated with Tamoxifen","volume":"9","author":"Sensorn","year":"2016","journal-title":"Onco. Targets Ther."},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B257","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A Human Neutralizing Antibody Targets the Receptor-Binding Site of SARS-CoV-2","volume":"584","author":"Shi","year":"","journal-title":"Nature"},{"key":"B258","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbrc.2020.08.086","article-title":"Andrographolide and its Fluorescent Derivative Inhibit the Main Proteases of 2019-nCoV and SARS-CoV through Covalent Linkage","volume":"533","author":"Shi","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12272-020-01294-3","article-title":"ABCB1 c.2677G>T\/c.3435C>T Diplotype Increases the Early-phase Oral Absorption of Losartan","volume":"43","author":"Shin","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"B260","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3949\/ccjm.85a.17034","article-title":"Hydroxychloroquine: An Old Drug with New Relevance","volume":"85","author":"Shippey","year":"2018","journal-title":"Cleve. Clin. J. Med."},{"key":"B261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1810778","article-title":"Targeting COVID-19 (SARS-CoV-2) Main Protease through Active Phytochemicals of Ayurvedic Medicinal Plants - Withania Somnifera (Ashwagandha), Tinospora Cordifolia (Giloy) and Ocimum Sanctum (Tulsi) - a Molecular Docking Study","author":"Shree","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B262","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.14535","article-title":"Increased Risk of Acute Stroke Among Patients with Severe COVID-19: a Multicenter Study and Meta-Analysis","volume":"28","author":"Siepmann","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13205-020-02610-w","article-title":"Screening of Potent Drug Inhibitors against SARS-CoV-2 RNA Polymerase: an In Silico Approach","volume":"11","author":"Singh","year":"2021","journal-title":"3 Biotech."},{"key":"B264","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1111\/bjh.16968","article-title":"COVID-19 Mortality in Patients on Anticoagulants and Antiplatelet Agents","volume":"190","author":"Sivaloganathan","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ageing\/afaa274","article-title":"Efficacy and Safety of COVID-19 Vaccines in Older People","volume":"50","author":"Soiza","year":"2021","journal-title":"Age Ageing"},{"key":"B266","doi-asserted-by":"publisher","first-page":"114999","DOI":"10.1016\/j.molliq.2020.114999","article-title":"Computational Study on Peptidomimetic Inhibitors against SARS-CoV-2 Main Protease","volume":"322","author":"Somboon","year":"2021","journal-title":"J. Mol. Liq."},{"key":"B267","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2217\/pgs-2016-0151","article-title":"Genetic Variation in the Glucocorticoid Pathway Involved in Interindividual Differences in the Glucocorticoid Treatment","volume":"18","author":"Song","year":"2017","journal-title":"Pharmacogenomics"},{"key":"B268","doi-asserted-by":"publisher","first-page":"e1007236","DOI":"10.1371\/journal.ppat.1007236","article-title":"Cryo-EM Structure of the SARS Coronavirus Spike Glycoprotein in Complex with its Host Cell Receptor ACE2","volume":"14","author":"Song","year":"2018","journal-title":"Plos Pathog."},{"key":"B269","doi-asserted-by":"publisher","first-page":"106080","DOI":"10.1016\/j.ijantimicag.2020.106080","article-title":"COVID-19 Treatment: Close to a Cure? A Rapid Review of Pharmacotherapies for the Novel Coronavirus (SARS-CoV-2)","volume":"56","author":"Song","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B270","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence","volume":"108","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2021.1897682","article-title":"An In-Silico Approach to Identify the Potential Hot Spots in SARS-CoV-2 Spike RBD to Block the Interaction with ACE2 Receptor","author":"Stalin","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B272","doi-asserted-by":"publisher","first-page":"173644","DOI":"10.1016\/j.ejphar.2020.173644","article-title":"Treatment for COVID-19: An Overview","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083957","article-title":"SARS-CoV-2 Papain-like Protease Potential Inhibitors-In Silico Quantitative Assessment","volume":"22","author":"Stasiulewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/japtr.JAPTR_84_20","article-title":"The Coronavirus Disease 2019 Main Protease Inhibitor from Andrographis Paniculata","volume":"11","author":"Sukardiman","year":"2020","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"B275","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/jcla.21820","article-title":"Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers","volume":"30","author":"Sukasem","year":"","journal-title":"J. Clin. Lab. Anal."},{"key":"B276","doi-asserted-by":"publisher","first-page":"2780272","DOI":"10.1155\/2018\/2780272","article-title":"Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients","volume":"2018","author":"Sukasem","year":"","journal-title":"J. Immunol. Res."},{"key":"B277","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2133\/dmpk.dmpk-13-rg-077","article-title":"Pharmacogenetics and Clinical Biomarkers for Subtherapeutic Plasma Efavirenz Concentration in HIV-1 Infected Thai Adults","volume":"29","author":"Sukasem","year":"","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1365-2125.2012.04288.x","article-title":"Pharmacogenetic Markers of CYP2B6 Associated with Efavirenz Plasma Concentrations in HIV-1 Infected Thai Adults","volume":"74","author":"Sukasem","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"100399","DOI":"10.1016\/j.dmpk.2021.100399","article-title":"Pharmacogenomics Research and its Clinical Implementation in Thailand: Lessons Learned from the Resource-Limited Settings","volume":"39","author":"Sukasem","year":"","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B280","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fphar.2016.00186","article-title":"HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand","volume":"7","author":"Sukasem","year":"","journal-title":"Front. Pharmacol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev-genom-083115-022324","article-title":"Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics","volume":"19","author":"Sukasem","year":"","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B282","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/cpt.1915","article-title":"Genetic Association of Co-trimoxazole-induced Severe Cutaneous Adverse Reactions Is Phenotype-specific: HLA Class I Genotypes and Haplotypes","volume":"108","author":"Sukasem","year":"","journal-title":"Clin. Pharmacol. Ther."},{"key":"B283","first-page":"111","article-title":"Pharmacogenomics of Drug-Induced Hypersensitivity Reactions: Challenges, Opportunities and Clinical Implementation","volume":"32","author":"Sukasem","year":"","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-021-00247-3","article-title":"Spectrum of Cutaneous Adverse Reactions to Aromatic Antiepileptic Drugs and Human Leukocyte Antigen Genotypes in Thai Patients and Meta-Analysis","author":"Sukasem","year":"","journal-title":"Pharmacogenomics J."},{"key":"B285","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.4979","article-title":"Genetic and Clinical Risk Factors Associated with Phenytoin-Induced Cutaneous Adverse Drug Reactions in Thai Population","volume":"29","author":"Sukasem","year":"","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B286","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/PGPM.S42332","article-title":"CYP2C19 Polymorphisms in the Thai Population and the Clinical Response to Clopidogrel in Patients with Atherothrombotic-Risk Factors","volume":"6","author":"Sukasem","year":"2013","journal-title":"Pharmgenomics. Pers. Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"12343","DOI":"10.1038\/s41598-021-90969-y","article-title":"Allele Frequencies of Single Nucleotide Polymorphisms of Clinically Important Drug-Metabolizing Enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai Population","volume":"11","author":"Sukprasong","year":"2021","journal-title":"Sci. Rep."},{"key":"B288","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cpt.1866","article-title":"Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System","volume":"108","author":"Sun","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B289","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7883\/yoken.JJID.2013.190","article-title":"Polymorphisms of the ApoE (Apolipoprotein E) Gene and Their Influence on Dyslipidemia in HIV-1-Infected Individuals","volume":"68","author":"Suwalak","year":"2015","journal-title":"Jpn. J. Infect. Dis."},{"key":"B290","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/bab.2159","article-title":"Discovery of Potent Covid-19 Main Protease Inhibitors Using Integrated Drug-Repurposing Strategy","volume":"68","author":"T","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"key":"B291","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural Basis of SARS-CoV-2 3CL(pro) and Anti-COVID-19 Drug Discovery from Medicinal Plants","volume":"10","author":"Tahir Ul Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"B292","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41525-020-00143-y","article-title":"Pharmacogenomics of COVID-19 Therapies","volume":"5","author":"Takahashi","year":"2020","journal-title":"NPJ Genomic Med."},{"key":"B293","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41397-019-0117-x","article-title":"CYP2C9, VKORC1, and CYP4F2 Polymorphisms and Pediatric Warfarin Maintenance Dose: a Systematic Review and Meta-Analysis","volume":"20","author":"Takeuchi","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"B294","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1093\/hmg\/ddr249","article-title":"Genome-wide Association Study Identified ITPA\/DDRGK1 Variants Reflecting Thrombocytopenia in Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C","volume":"20","author":"Tanaka","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-021-01014-y","article-title":"Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-Analysis","author":"Tao","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"B296","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/clpt.2012.13","article-title":"Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans","volume":"92","author":"Tarkiainen","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B297","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing Monoclonal Antibodies for Treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010081","article-title":"Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters","volume":"13","author":"Telbisz","year":"2021","journal-title":"Pharmaceutics"},{"key":"B299","doi-asserted-by":"publisher","first-page":"599079","DOI":"10.3389\/fmolb.2020.599079","article-title":"In Silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19","volume":"7","author":"Teli","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B300","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FPC.0000000000000306","article-title":"Dapsone-induced Severe Cutaneous Adverse Drug Reactions Are Strongly Linked with HLA-B*13: 01 Allele in the Thai Population","volume":"27","author":"Tempark","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"B301","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cpt.1830","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs","volume":"108","author":"Theken","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21020211","article-title":"Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-retroviral Therapy (HAART) in Resource-Limited Settings","volume":"21","author":"Thomford","year":"2016","journal-title":"Molecules"},{"key":"B303","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1021\/jm050852f","article-title":"Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies","volume":"49","author":"Tsai","year":"2006","journal-title":"J. Med. Chem."},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2018-0042","article-title":"Drug-drug Interaction (DDI) Assessments of Ruxolitinib, a Dual Substrate of CYP3A4 and CYP2C9, Using a Verified Physiologically Based Pharmacokinetic (PBPK) Model to Support Regulatory Submissions","volume":"34","author":"Umehara","year":"2019","journal-title":"Drug Metab. Pers. Ther."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial Cell Infection and Endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet (London, England)"},{"key":"B306","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40264-020-00938-z","article-title":"Critical Assessment of Pharmacokinetic Drug-Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment","volume":"43","author":"Veeravalli","year":"2020","journal-title":"Drug Saf."},{"key":"B307","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"B308","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/QAD.0b013e3282f37812","article-title":"HLA-DRB1*01 Associated with Cutaneous Hypersensitivity Induced by Nevirapine and Efavirenz","volume":"22","author":"Vitezica","year":"2008","journal-title":"AIDS"},{"key":"B309","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/pme-2020-0183","article-title":"Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug against SARS-CoV-2 Infection","volume":"18","author":"Vohra","year":"2021","journal-title":"Per. Med."},{"key":"B310","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) In Vitro","volume":"30","author":"Wang","year":"","journal-title":"Cell Res"},{"key":"B311","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"","journal-title":"Cell"},{"key":"B312","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1038\/emi.2015.28","article-title":"The Role of C5a in Acute Lung Injury Induced by Highly Pathogenic Viral Infections","volume":"4","author":"Wang","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"B313","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/jmv.26625","article-title":"The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors Is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-Analysis","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol."},{"key":"B314","unstructured":"Coronavirus Disease (COVID-2019) Situation Reports\n            Who\n          2021"},{"key":"B315","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7326\/L20-120610.7326\/M20-2003","article-title":"Autopsy Findings and Venous Thromboembolism in Patients with COVID-19","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"B316","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"B317","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.2174\/1381612824666181018153641","article-title":"Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-Analysis","volume":"24","author":"Xie","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"B318","doi-asserted-by":"publisher","first-page":"12256","DOI":"10.1021\/acs.jmedchem.0c00502","article-title":"Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities","volume":"63","author":"Xiu","year":"2020","journal-title":"J. Med. Chem."},{"key":"B319","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00277-014-2170-5","article-title":"UGT1A1 *6 Polymorphism Predicts Outcome in Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Carboplatin, Dexamethasone, Etoposide and Irinotecan","volume":"94","author":"Yamasaki","year":"2015","journal-title":"Ann. Hematol."},{"key":"B320","doi-asserted-by":"publisher","first-page":"111764","DOI":"10.1016\/j.biopha.2021.111764","article-title":"Theobroma Cacao L. Compounds: Theoretical Study and Molecular Modeling as Inhibitors of Main SARS-CoV-2 Protease","volume":"140","author":"Ya\u00f1ez","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B321","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular Interaction and Inhibition of SARS-CoV-2 Binding to the ACE2 Receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12815","article-title":"What Do We Know about Remdesivir Drug Interactions?","author":"Yang","year":"2020","journal-title":"Clin. Transl. Sci"},{"key":"B323","doi-asserted-by":"publisher","first-page":"6679761","DOI":"10.1155\/2021\/6679761","article-title":"The Hydroalcoholic Extract of Uncaria Tomentosa (Cat\u2019s Claw) Inhibits the Infection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In Vitro","volume":"2021","author":"Yepes-Perez","year":"2021","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"B324","doi-asserted-by":"publisher","first-page":"4932572","DOI":"10.1155\/2020\/4932572","article-title":"Investigating Potential Inhibitory Effect of Uncaria Tomentosa (Cat\u2019s Claw) against the Main Protease 3CL(pro) of SARS-CoV-2 by Molecular Modeling","volume":"2020","author":"Yepes-P\u00e9rez","year":"2020","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"B325","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural Basis for Inhibition of the RNA-dependent RNA Polymerase from SARS-CoV-2 by Remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-18","article-title":"Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses","volume":"62","author":"Yoon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B327","doi-asserted-by":"publisher","first-page":"114296","DOI":"10.1016\/j.bcp.2020.114296","article-title":"Repurposing Existing Drugs for the Treatment of COVID-19\/sars-CoV-2 Infection: A Review Describing Drug Mechanisms of Action","volume":"183","author":"Yousefi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050893","article-title":"Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase","volume":"9","author":"Zandi","year":"2021","journal-title":"Microorganisms"},{"key":"B329","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/QAD.0b013e32830b3a96","article-title":"Genetic Polymorphisms Differently Influencing the Emergence of Atrophy and Fat Accumulation in HIV-Related Lipodystrophy","volume":"22","author":"Zanone Poma","year":"2008","journal-title":"AIDS"},{"key":"B330","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/004982598239597","article-title":"Identification of Cytochrome P4503A4 as the Major Enzyme Responsible for the Metabolism of Ivermectin by Human Liver Microsomes","volume":"28","author":"Zeng","year":"1998","journal-title":"Xenobiotica"},{"key":"B331","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine Release Syndrome in Severe COVID-19: Interleukin-6 Receptor Antagonist Tocilizumab May Be the Key to Reduce Mortality","volume":"55","author":"Zhang","year":"","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B332","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.joim.2020.02.005","article-title":"In Silico screening of Chinese Herbal Medicines with the Potential to Directly Inhibit 2019 Novel Coronavirus","volume":"18","author":"Zhang","year":"","journal-title":"J. Integr. Med."},{"key":"B333","doi-asserted-by":"publisher","first-page":"111998","DOI":"10.1016\/j.fct.2021.111998","article-title":"Inhibition of Drug-Metabolizing Enzymes by Qingfei Paidu Decoction: Implication of Herb-Drug Interactions in COVID-19 Pharmacotherapy","volume":"149","author":"Zhang","year":"","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"B334","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-021-00697-2","article-title":"Inhibition of Drug-Metabolizing Enzymes by Jingyin Granules: Implications of Herb-Drug Interactions in Antiviral Therapy","author":"Zhang","year":"","journal-title":"Acta Pharmacol. Sin."},{"key":"B335","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved \u03b1-ketoamide Inhibitors","volume":"368","author":"Zhang","year":"","journal-title":"Science"},{"key":"B336","doi-asserted-by":"publisher","first-page":"790469","DOI":"10.3389\/fimmu.2021.790469","article-title":"Endogenous Antibody Responses to SARS-CoV-2 in Patients with Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together","volume":"12","author":"Zhang","year":"","journal-title":"Front. Immunol."},{"key":"B337","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1182\/bloodadvances.2019000311","article-title":"Association between the HLA-Drb1*03:01-Dqb1*02:01 Haplotype and PF4\/heparin Antibodies","volume":"3","author":"Zhang","year":"2019","journal-title":"Blood Adv."},{"key":"B338","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/13880209.2018.1478431","article-title":"Influence of Andrographolide on the Pharmacokinetics of Warfarin in Rats","volume":"56","author":"Zhang","year":"2018","journal-title":"Pharm. Biol."},{"key":"B339","doi-asserted-by":"publisher","first-page":"159","DOI":"10.31083\/j.rcm.2021.01.238","article-title":"Cardiovascular Complications of SARS-CoV-2 Infection (COVID-19): a Systematic Review and Meta-Analysis","volume":"22","author":"Zhao","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"key":"B340","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cpt.690","article-title":"Worldwide Distribution of Cytochrome P450 Alleles: A Meta-Analysis of Population-Scale Sequencing Projects","volume":"102","author":"Zhou","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B341","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults Aged 18 Years or Older: a Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"B342","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing Spondylitis: Etiology, Pathogenesis, and Treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res."},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26175230","article-title":"GC-MS, LC-MS\/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-chymotrypsin-like Protease Inhibitors from Zingiber Officinale Roscoe","volume":"26","author":"Zubair","year":"2021","journal-title":"Molecules"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T07:07:27Z","timestamp":1645168047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":343,"alternative-id":["10.3389\/fphar.2022.835136"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.835136","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"835136"}}